---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-161591"
form_type: "8-K"
ticker: "CYCN"
cik: "0001755237"
company_name: "Cyclerion Therapeutics, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:22:34.049306+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Cyclerion Therapeutics shareholders re-elect all five directors, ratify Ernst & Young as auditor

## Summary
- Each of five director nominees (De Souza, Hecht, Hyman, Higgins, Katabi) elected with for votes ranging from 1,670,155 to 1,688,966.
- Ernst & Young ratified as independent auditor for FY 2024 with 2,140,990 votes for, 47,974 against, 8,751 abstain.
- Proposal to adjourn annual meeting if necessary approved with 2,111,217 for, 86,202 against, 296 abstain.
- Broker non-votes on director election were 454,351 for each nominee; no other proposals had broker non-votes.

## SEC filing metadata
- accession: 0001193125-24-161591
- form_type: 8-K
- ticker: CYCN
- cik: 0001755237
- company_name: Cyclerion Therapeutics, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1755237/000119312524161591/0001193125-24-161591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1755237/000119312524161591/d811748d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-161591
- JSON: https://secwatch.observer/filing/0001193125-24-161591.json
- Plain text: https://secwatch.observer/filing/0001193125-24-161591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.